Profile
Arturo O.
Araya worked as an Associate Director-Marketing Intelligence at Bristol Myers Squibb Co. from 1999 to 2002.
He then worked as Vice President & Head-Global Commercial at Novartis Pharmaceuticals Corp.
from 2014 to 2016.
From 2017 to 2021, he worked as Chief Commercial Officer at Brainstorm Cell Therapeutics, Inc. Araya received his undergraduate and graduate degrees from the University of Connecticut and his MBA from the University of Michigan.
Former positions of Arturo O. Araya
Companies | Position | End |
---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Director/Board Member | 2018-11-28 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2016-06-30 |
BRISTOL-MYERS SQUIBB COMPANY | Sales & Marketing | 2001-12-31 |
Training of Arturo O. Araya
University of Michigan | Masters Business Admin |
University of Connecticut | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private companies | 1 |
---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Arturo O. Araya